Logo image of AVPT

AVEPOINT INC (AVPT) Stock Fundamental Analysis

NASDAQ:AVPT - Nasdaq - US0536041041 - Common Stock - Currency: USD

18.56  +0.06 (+0.32%)

After market: 18.56 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AVPT. AVPT was compared to 281 industry peers in the Software industry. AVPT has an excellent financial health rating, but there are some minor concerns on its profitability. AVPT is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year AVPT was profitable.
In the past year AVPT had a positive cash flow from operations.
In the past 5 years AVPT always reported negative net income.
Of the past 5 years AVPT 4 years had a positive operating cash flow.
AVPT Yearly Net Income VS EBIT VS OCF VS FCFAVPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

AVPT has a Return On Assets (-4.00%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -6.66%, AVPT is in line with its industry, outperforming 55.67% of the companies in the same industry.
The Return On Invested Capital of AVPT (2.76%) is better than 71.28% of its industry peers.
Industry RankSector Rank
ROA -4%
ROE -6.66%
ROIC 2.76%
ROA(3y)-6.84%
ROA(5y)-13.69%
ROE(3y)-13.09%
ROE(5y)-73.41%
ROIC(3y)N/A
ROIC(5y)N/A
AVPT Yearly ROA, ROE, ROICAVPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

Looking at the Operating Margin, with a value of 3.91%, AVPT is in the better half of the industry, outperforming 69.50% of the companies in the same industry.
AVPT has a Gross Margin of 75.36%. This is in the better half of the industry: AVPT outperforms 67.38% of its industry peers.
AVPT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.91%
PM (TTM) N/A
GM 75.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.79%
AVPT Yearly Profit, Operating, Gross MarginsAVPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVPT is destroying value.
Compared to 1 year ago, AVPT has more shares outstanding
AVPT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for AVPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AVPT Yearly Shares OutstandingAVPT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
AVPT Yearly Total Debt VS Total AssetsAVPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 9.79 indicates that AVPT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.79, AVPT belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
AVPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.79
ROIC/WACC0.24
WACC11.47%
AVPT Yearly LT Debt VS Equity VS FCFAVPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 2.15 indicates that AVPT has no problem at all paying its short term obligations.
The Current ratio of AVPT (2.15) is better than 64.89% of its industry peers.
AVPT has a Quick Ratio of 2.15. This indicates that AVPT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.15, AVPT is in the better half of the industry, outperforming 65.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 2.15
AVPT Yearly Current Assets VS Current LiabilitesAVPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for AVPT have decreased strongly by -36.36% in the last year.
Looking at the last year, AVPT shows a very strong growth in Revenue. The Revenue has grown by 21.70%.
The Revenue has been growing by 23.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)21.7%
Revenue growth 3Y19.86%
Revenue growth 5Y23.27%
Sales Q2Q%24.86%

3.2 Future

Based on estimates for the next years, AVPT will show a very strong growth in Earnings Per Share. The EPS will grow by 110.93% on average per year.
Based on estimates for the next years, AVPT will show a very strong growth in Revenue. The Revenue will grow by 23.07% on average per year.
EPS Next Y440.6%
EPS Next 2Y162.72%
EPS Next 3Y110.93%
EPS Next 5YN/A
Revenue Next Year21.89%
Revenue Next 2Y19.88%
Revenue Next 3Y20.62%
Revenue Next 5Y23.07%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AVPT Yearly Revenue VS EstimatesAVPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M
AVPT Yearly EPS VS EstimatesAVPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

AVPT is valuated quite expensively with a Price/Earnings ratio of 265.14.
AVPT's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.05. AVPT is valued rather expensively when compared to this.
AVPT is valuated quite expensively with a Price/Forward Earnings ratio of 53.78.
The rest of the industry has a similar Price/Forward Earnings ratio as AVPT.
AVPT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 37.67.
Industry RankSector Rank
PE 265.14
Fwd PE 53.78
AVPT Price Earnings VS Forward Price EarningsAVPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AVPT.
Based on the Price/Free Cash Flow ratio, AVPT is valued a bit cheaper than 61.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 50.69
EV/EBITDA 185.97
AVPT Per share dataAVPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AVPT's earnings are expected to grow with 110.93% in the coming years.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y162.72%
EPS Next 3Y110.93%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVEPOINT INC

NASDAQ:AVPT (7/25/2025, 8:00:01 PM)

After market: 18.56 0 (0%)

18.56

+0.06 (+0.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners62.82%
Inst Owner Change0.09%
Ins Owners34.06%
Ins Owner Change-5.88%
Market Cap3.93B
Analysts80
Price Target21.13 (13.85%)
Short Float %3.97%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-85.69%
Min EPS beat(2)-180.31%
Max EPS beat(2)8.93%
EPS beat(4)2
Avg EPS beat(4)-73.12%
Min EPS beat(4)-180.31%
Max EPS beat(4)18.43%
EPS beat(8)5
Avg EPS beat(8)-31.36%
EPS beat(12)8
Avg EPS beat(12)-45.2%
EPS beat(16)9
Avg EPS beat(16)-588.81%
Revenue beat(2)1
Avg Revenue beat(2)1.11%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)2.91%
Revenue beat(4)3
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-0.69%
Max Revenue beat(4)4.41%
Revenue beat(8)7
Avg Revenue beat(8)2.22%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)11
Avg Revenue beat(16)0.58%
PT rev (1m)2.11%
PT rev (3m)9.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)23.2%
EPS NY rev (1m)0%
EPS NY rev (3m)6%
Revenue NQ rev (1m)0.73%
Revenue NQ rev (3m)4.51%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)4.46%
Valuation
Industry RankSector Rank
PE 265.14
Fwd PE 53.78
P/S 11.27
P/FCF 50.69
P/OCF 48.17
P/B 10.94
P/tB 12.64
EV/EBITDA 185.97
EPS(TTM)0.07
EY0.38%
EPS(NY)0.35
Fwd EY1.86%
FCF(TTM)0.37
FCFY1.97%
OCF(TTM)0.39
OCFY2.08%
SpS1.65
BVpS1.7
TBVpS1.47
PEG (NY)0.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4%
ROE -6.66%
ROCE 3.5%
ROIC 2.76%
ROICexc 27.77%
ROICexgc N/A
OM 3.91%
PM (TTM) N/A
GM 75.36%
FCFM 22.23%
ROA(3y)-6.84%
ROA(5y)-13.69%
ROE(3y)-13.09%
ROE(5y)-73.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.79%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 72.45%
Cap/Sales 1.16%
Interest Coverage 250
Cash Conversion 424.02%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 2.15
Altman-Z 9.79
F-Score5
WACC11.47%
ROIC/WACC0.24
Cap/Depr(3y)70.47%
Cap/Depr(5y)101.2%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y440.6%
EPS Next 2Y162.72%
EPS Next 3Y110.93%
EPS Next 5YN/A
Revenue 1Y (TTM)21.7%
Revenue growth 3Y19.86%
Revenue growth 5Y23.27%
Sales Q2Q%24.86%
Revenue Next Year21.89%
Revenue Next 2Y19.88%
Revenue Next 3Y20.62%
Revenue Next 5Y23.07%
EBIT growth 1Y240.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.86%
EBIT Next 3Y35.86%
EBIT Next 5YN/A
FCF growth 1Y2122.84%
FCF growth 3Y222.06%
FCF growth 5YN/A
OCF growth 1Y1136.86%
OCF growth 3Y160.48%
OCF growth 5YN/A